On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Ospedale San Luigi Gonzaga

InstitutionResearch output, impact & collaborations

Ospedale San Luigi Gonzaga is a institution indexed in ScholarIQ from OpenAlex.

What is known about Ospedale San Luigi Gonzaga?

ScholarIQrecord summary

Ospedale San Luigi Gonzaga is a research organisation in Orbassano, IT. OpenAlex records 5,765 works and 430,338 citations for it. 1,161 researchers list it as their most recent affiliation.

How many works does Ospedale San Luigi Gonzaga have?

ScholarIQindexed works

Ospedale San Luigi Gonzaga has 5,765 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Ospedale San Luigi Gonzaga have?

ScholarIQcitation count

Ospedale San Luigi Gonzaga has 430,338 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Ospedale San Luigi Gonzaga?

ScholarIQresearcher count

Ospedale San Luigi Gonzaga has 1,161 researchers in the ScholarIQ index.

What is the average h-index at Ospedale San Luigi Gonzaga?

ScholarIQavg h-index

Ospedale San Luigi Gonzaga has an average h-index of 80 in OpenAlex.

What is the ROR of Ospedale San Luigi Gonzaga?

ScholarIQror

The ROR for Ospedale San Luigi Gonzaga is on the source record.

What is the OpenAlex record for Ospedale San Luigi Gonzaga?

ScholarIQopenalex

The OpenAlex for Ospedale San Luigi Gonzaga is on the source record.

Who are the most-cited researchers behind Ospedale San Luigi Gonzaga?

ScholarIQtop researchers by citations
1
Giorgio V. Scagliotti · Lung Cancer Treatments and Mutations
1,044 works51,488 citations
2
Massimo Terzolo · Adrenal and Paraganglionic Tumors
490 works22,973 citations
3
Giuseppe Poli · Cholesterol and Lipid Metabolism
370 works20,182 citations

What are the most-cited papers on Ospedale San Luigi Gonzaga?

ScholarIQmost cited works
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch, Giorgio V. Scagliotti, James L. Mulshine, Regina Kwon, Walter J. Curran, Yi‐Long Wu, Luis Paz‐Ares
The Lancet. 20163,375 CitationsOPEN ACCESS
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, U. Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Göksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David R. Gandara
Journal of Clinical Oncology. 20083,230 Citations
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti, Jean-Yves Douillard, Frances A. Shepherd, Richard Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour, Stephen Spiro, Estelle Rolland, Roldano Fossati, D. Aubert, Keyue Ding, David Waller, Thierry Le Chevalier
Journal of Clinical Oncology. 20082,693 CitationsOPEN ACCESS
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
Martin Faßnacht, Wiebke Arlt, Irina Bancos, Henning Dralle, John Newell‐Price, Anju Sahdev, Antoine Tabarin, Massimo Terzolo, Stylianos Tsagarakis, Olaf M Dekkers
European Journal of Endocrinology. 20161,554 CitationsOPEN ACCESS
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Andrew G. Nicholson, Ming‐Sound Tsao, Mary Beth Beasley, Alain Borczuk, Élisabeth Brambilla, Wendy A. Cooper, Sanja Đačić, Deepali Jain, Keith M. Kerr, Sylvie Lantuéjoul, Masayuki Noguchi, Mauro Papotti, Natasha Rekhtman, Giorgio V. Scagliotti, Paul Van Schil, Lynette M. Sholl, Yasushi Yatabe, Akihiko Yoshida, William D. Travis
Journal of Thoracic Oncology. 20211,534 CitationsOPEN ACCESS

How much of the research on Ospedale San Luigi Gonzaga is open access?

ScholarIQopen access share
92%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
17%
Bronze
58%
Closed
8%

Related on ScholarIQ

470M+ articles · 14-day free trial